Kuo Tsung-Rong, Chen Chih-Hwa
Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 11031 Taiwan.
International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 11031 Taiwan.
Biomark Res. 2017 May 18;5:18. doi: 10.1186/s40364-017-0097-4. eCollection 2017.
Bone biomarkers included formation, resorption and regulator are released during the bone remodeling processes. These bone biomarkers have attracted much attention in the clinical assessment of osteoporosis treatment in the past decade. Combination with the measurement of bone mineral density, the clinical applications of bone biomarkers have provided comprehensive information for diagnosis of osteoporosis. However, the analytical approaches of the bone biomarkers are still the challenge for further clinical trials. In this mini-review, we have introduced the functions of bone biomarkers and then recently developed techniques for bone biomarker measurements have been systematically integrated to discuss the possibility for osteoporosis assessment in the early stage.
骨生物标志物包括在骨重塑过程中释放的形成、吸收和调节标志物。在过去十年中,这些骨生物标志物在骨质疏松症治疗的临床评估中备受关注。结合骨密度测量,骨生物标志物的临床应用为骨质疏松症的诊断提供了全面信息。然而,骨生物标志物的分析方法仍然是进一步临床试验面临的挑战。在本综述中,我们介绍了骨生物标志物的功能,然后系统地整合了最近开发的骨生物标志物测量技术,以探讨早期评估骨质疏松症的可能性。